Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Equillium to Participate in Upcoming Investor Conferences

globenewswire.com
EQ The article announces Equillium's participation in upcoming investor conferences, which is a standard corporate activity and does not inherently suggest positive or negative performance.

Equillium to Participate in Upcoming Investor Conferences LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Stifel 2026 Healthcare Conference

Format: Fireside Chat & 1x1 Meetings

Date: Thursday, November 12, 2026

Time: 9:20 AM EST

2026 Jefferies Global Healthcare Conference in London

Format: 1x1 Meetings

Date: Tuesday, November 17 – Thursday, November 19, 2026

Members of the Equillium management team will be available to meet with investors who are registered to attend each conference.

About Equillium

Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact

PJ Kelleher

LifeSci Advisors, LLC

+1-617-430-7579

pkelleher@lifesciadvisors.com